Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. (2018)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.14700.2
PubMed Identifier: 30175246
Publication URI: http://europepmc.org/abstract/MED/30175246
Type: Journal Article/Review
Volume: 3
Parent Publication: Wellcome open research
ISSN: 2398-502X